Enlivex Therapeutics Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 08/14/2026 | 2.38 M | $1.31 M | 279.23% | 5.24% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2026 | 321.31 K | $176.69 K | 42.34% | 0.71% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 193.15 K | $106.04 K | 48.12% | 0.43% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 183.92 K | $101.14 K | 25.62% | 0.40% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 157.65 K | $86.69 K | 1,428.49% | 0.35% |
| PERSISTENT ASSET PARTNERS LTD | 08/07/2026 | 147.88 K | $81.32 K | 100.00% | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 133.90 K | $73.63 K | 4.45% | 0.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 129.86 K | $71.41 K | 61.19% | 0.29% |
| JPMORGAN CHASE & CO | 08/12/2026 | 121.30 K | $70.35 K | -3.69% | 0.27% |
| SIMPLEX TRADING, LLC | 08/12/2026 | 111.41 K | $61.26 K | 4,160.27% | 0.25% |
| WINTON GROUP LTD | 08/07/2026 | 99.22 K | $54.56 K | 100.00% | 0.22% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 89.42 K | $49.17 K | -12.42% | 0.20% |
| CITADEL ADVISORS LLC | 09/02/2026 | 88.40 K | $48.61 K | 266.81% | 0.19% |
| UBS GROUP AG | 08/13/2026 | 73.91 K | $40.65 K | -46.57% | 0.16% |
| HRT FINANCIAL LP | 08/14/2026 | 49.66 K | $27.00 K | 100.00% | 0.11% |
| JANE STREET GROUP, LLC | 08/14/2026 | 41.20 K | $22.66 K | 100.00% | 0.09% |
| XTX TOPCO LTD | 08/14/2026 | 21.88 K | $12.03 K | -78.20% | 0.05% |
| CHICO WEALTH RIA | 08/13/2026 | 15.80 K | $8.69 K | 100.00% | 0.03% |
| MORGAN STANLEY | 08/13/2026 | 8.50 K | $4.67 K | -91.36% | 0.02% |
| MCGUIRE CAPITAL ADVISORS INC | 08/14/2026 | 2.50 K | $1.38 K | 0.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 1.04 K | $573 | 403.38% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 07/16/2026 | 1.00 K | $550 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/13/2026 | 500 | $275 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 402 | $221 | -65.70% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 200 | $110 | -97.87% | 0.00% |
| DARWIN WEALTH MANAGEMENT, LLC | 07/21/2026 | 150 | $82 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 1 | $1 | 0.00% | 0.00% |
| US BANCORP \DE\ | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| INVESCO LTD. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 09/02/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| NEUBERGER BERMAN GROUP LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 08/10/2026 | 0 | $0 | -100.00% | 0.00% |
| DIAMETRIC CAPITAL, LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SKYVIEW INVESTMENT ADVISORS, LLC | 09/15/2026 | 0 | $0 | -100.00% | 0.00% |
| PROSPERITY CONSULTING GROUP, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 07/27/2026 | 0 | $0 | -100.00% | 0.00% |
Enlivex Therapeutics Ltd institutional Ownership - FAQ's
During the previous two years, 42 institutional investors and hedge funds held shares of Enlivex Therapeutics Ltd. The most heavily invested institutionals were:
ARK Investment Management LLC: 2.38 M
PRELUDE CAPITAL MANAGEMENT, LLC: 321,306
BANK OF AMERICA CORP /DE/: 193,150
TWO SIGMA INVESTMENTS, LP: 183,924
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 157,648
Persistent Asset Partners Ltd: 147,879
9.35% of Enlivex Therapeutics Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 4.25 M shares in the last 24 months. This purchase volume represents approximately $4.93 M in transactions.